Hellenic Cooperative Oncology Group
Clinical trials sponsored by Hellenic Cooperative Oncology Group, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Real-world data may reveal true value of abemaciclib for advanced breast cancer Results expected Nov 2026 (estimated)
-
Can a Four-Drug cocktail tame pancreatic cancer? a Real-World trial seeks answers
Disease control Recruiting nowThis study follows about 70 people with metastatic pancreatic cancer who are receiving NalIriFOx as their first treatment. Researchers are collecting real-world data to see how well the drug combination controls the disease and what side effects occur. The goal is to understand w…
Sponsor: Hellenic Cooperative Oncology Group • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Real-world data may reveal true value of abemaciclib for advanced breast cancer
Disease control Recruiting nowThis study tracks 108 patients with HR-positive, HER2-negative advanced breast cancer who are receiving abemaciclib combined with hormone therapy. Researchers are collecting real-world data on how long patients live without their cancer worsening, overall survival, and side effec…
Sponsor: Hellenic Cooperative Oncology Group • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC